MedTrace Logo

Use of N-Acetylcysteine (NAC) in Fingernail Biting

NCT01993849 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2018-10-03

Study results available
· View outcomes & findings →

Summary

To conduct a pilot randomized placebo-controlled feasibility trial of N-acetylcysteine (NAC) in onychophagia, preliminarily assessing the tolerability and effects of this pharmacotherapy on young adults who bite their fingernails. It is proposed that NAC will help decrease fingernail biting.

Conditions

  • Onychophagia

Interventions

DRUG

N-Acetylcysteine (NAC)

This is the medication N-acetylcysteine (NAC)

OTHER

Placebo

Placebo, designed to match in appearance to NAC

Sponsors & Collaborators

  • Kevin Gray, MD

    lead OTHER

Principal Investigators

  • Kevin M Gray, MD · Medical University of South Carolina

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01993849 on ClinicalTrials.gov